Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy | Genome Medicine | Full Text

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy | Genome Medicine | Full Text

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Clear cell renal cell carcinoma (ccRCC) is the dominant subtype of renal cancer. With currently available therapies, cure of advanced and metastatic ccRCC is achieved only in rare cases. Here, we developed a w...

Authors:Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, Annika Nelde, Juliane S. Walz, Stefan Winter, Siahei Kandabarau, Florian Büttner, Mathias Haag, Linus Backert, Daniel J. Kowalewski, Steffen Rausch, Jörg Hennenlotter, Viktoria Stühler, Marcus Scharpf, Falko Fend…

Citation:Genome Medicine 2020 12:32

Content type:Research

Published on: 30 March 2020

• ViewFull Text
 
• ViewPDF